An Open-Label Phase II Study of Buparlisib (BKM120) in Patients with Relapsed and Refractory Diffuse Large B-Cell Lymphoma (DLBCL), Mantle Cell Lymphoma (MCL) and Follicular Lymphoma (FL)

Tarih

2015

Yazar

Younes, Anas
Salles, Gilles
Martinelli, Giovanni
Bociek, R. Gregory
Barrigon, Dolores Caballero
Gonzalez Barca, Eva
Kim, Won Seog

Üst veri

Tüm öğe kaydını göster

Özet

…

Kaynak

Blood

Cilt

126

Sayı

23

Bağlantı

https://hdl.handle.net/20.500.12712/13896

Koleksiyonlar